UK - AXA Investment Managers - a unit of AXA Group - has enhanced its equity research team with the addition of two new analysts.
Jan Keuppans joins the technology team from AXA IM’s operation in The Netherlands where he has worked for the past three years. He will be responsible for software and IT companies.
Keuppans previously worked for Corluy, a Belgian specialist securities house where he managed global equity portfolios. He also has experience in managing pan-European equity portfolios.
Chris Donnellan joins the pharmaceutical team from Datamonitor, the market research company, where he led a team conducting market research into key pharmaceutical products.
His earlier medical research career was gained at SmithKline Beecham.
By Madhu Kalia
Investors, driven by depressed interest rates, slower global economic growth and rich equity market valuations are examining non-traditional investment opportunities.
The registration deadline for the Workplace Savings & Benefits Awards 2019 is today.
This week's top stories were the DWP giving the green light to CDC and TPR granting extensions for 11 master trust authorisation applications.
Susan Martin says building strong foundations for business are the only way forward as the pensions industry is radically shaken up